In the surgically excised cases, expression of calpastatin, calpain-1 and calpain-2 was not associated with breast cancer specific survival in the total patient cohort (P=0.347, P=0.428, and P=0.220 respectively); no association with survival of the inflammatory or non-inflammatory subgroups was observed. The gene discussed is CAPN2; the disease is breast cancer.